Regeneron president: Single administration of COVID-19 antibody therapy 'will protect people' for many months

George Yancopoulos, the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals, says the company's COVID-19 monoclonal antibody therapy can treat people already infected or those who are immunocompromised and were exposed.